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Dear Editor, 
we read with great interest the two papers 
recently published by Torbiarczyk et al. [1] and 
Springer et al. [2] where the authors discuss the 
role of diagnostic procedures in patients with 
haemoptysis. In the first study the authors eval-
uated the role of bronchoscopy in identification 
of bleeding source: due to the low visualization 
rate of the site of bleeding (11%), they suggest 
a possible overuse of bronchoscopy in the di-
agnosis of haemoptysis, in particular in young 
patients with a non-massive bleeding. Recently 
an Italian group of study investigated the role of 
early bronchoscopy (performed within 48 hours 
the onset of the first symptom) in localization 
of the bleeding site and in diagnosis of its cause 
[3]. They concluded that an early bronchoscopy 
in the emergency department does not improve 
neither the rate of diagnosis nor the localization 
of the bleeding. Torbiarzyk et al too, in their arti-
cle discussion, seem to confirm a limited role of 
bronchoscopy for these two outcomes. 
Springer et al. [2] evaluated the efficacy of the 
bronchial artery embolization (BAE) in patients 
with haemoptysis, describing a high rate of suc-
cessful procedures. In a paper of Patrucco and 
colleagues, the authors describe the completion 
of a BAE in a patient with an arteriovenous mal-
formation with full resolution of the bleeding [3]. 
In clinical practice BAE is used to control massive 
haemoptysis, as a bridge to surgical resection 
or as a definitive therapy, in cases of recurrent 
haemoptysis and in patients who are unfit for 
surgical procedures [4]. Moreover, in some studies 
BAE is used in case of inconclusive endoscopic 
intervention [5].
A different topic is the massive haemoptysis 
that requires an intensive and prompt manage-
ment. In this case the role of fiberoptic and rigid 
bronchoscopy seems to be pivotal at least for the 
choice of the ipsilateral decubitus to the site of 
bleeding to protect the healthy lung and to save 
time for different procedures but such important 
bleedings represent only a small part of the cases 
admitted to the emergency department [6, 7]. 
Gavelli and colleagues aimed to improve the 
management of much more frequent mild-to-mod-
erate haemoptysis in their middle-size University 
hospital by proposing a clinical algorithm with 
different conclusions about the usefulness of 
fiberoptic endoscopic procedure [8]. It is a multi-
step approach that provides, in case of recurrent 
haemoptysis or in case of suspected neoplastic 
lesion or high risk for lung cancer, a computed 
tomography of the thorax. After the radiologic 
examination, each patient underwent as soon as 
possible a bronchoscopy with different goals, not 
only diagnostic but also therapeutic. BAE and sur-
gery were reserved respectively to non-neoplastic 
haemoptysis and neoplastic disease or uneffective 
BAE. Some important aspect of this approach is 
worthy to be underlined: in fact even if recent 
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literature doesn’t seem to suggest an endoscopic 
evaluation in case of a negative computed tomog-
raphy regarding a diagnostical point of view [9], 
a bronchoscopy is the only procedure able to 
have a therapeutical role after the definition of 
the bleeding source, giving a chance to a prompt 
and effective resolution of the cause, in acute and 
recurrent haemoptysis. In fact in high experienced 
centers with endoscopic oriented pulmonary units, 
during the procedures it is possible to treat some 
bleeding source with argon plasma coagulation, 
cryotherapy and deploy endobronchial stents [8]. 
Moreover it is important to highlight some other 
important usefulness of early bronchoscopy in 
non-life-threatening haemoptysis: it permits to 
collect a microbiologic and/or cytomorphologic 
sample of endobronchial secretions or lesions, 
with rapid and specific antibiotic administra-
tion, and, finally, it allows to visualize potential 
bleeding causes non detectable with computed 
tomography (i.e. haemorrhagic tracheobronchitis). 
Finally, it should be always kept in mind that in 
hemodynamically stable patients, without contra-
indications, bronchoscopy is a safe procedure, pro-
viding fundamental results despite low risks [10].
In conclusion the role of interventional pul-
monology in both the diagnostic and therapeutic 
aspects of haemopthysis is far to be completely 
defined. Even if we have to differentiate massive 
from mild and moderate bleeding it seems to be 
reasonable to asses that a bronchoscopy (fiberop-
tic or rigid) can be safely proposed in skilled cen-
ters with a wide range of immediate therapeutical 
interventional options, whether pneumological, 
either radiological or surgical.
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